XML 19 R6.htm IDEA: XBRL DOCUMENT
v3.23.2

CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY - USD ($) shares in Thousands, $ in Thousands | Total | Angi Inc. | IAC | Redeemable Noncontrolling Interests | Redeemable Noncontrolling Interests Vivian Health | Total IAC Shareholders' Equity | Total IAC Shareholders' Equity Angi Inc. | Total IAC Shareholders' Equity IAC | Common Stock Common Stock, $0.0001 par value | Common Stock Class B common stock, $0.0001 par value | Additional Paid-in-Capital | Additional Paid-in-Capital Angi Inc. | Retained Earnings (Accumulated Deficit) | Accumulated Other Comprehensive Income (Loss) | Accumulated Other Comprehensive Income (Loss) Angi Inc. | Treasury Stock | Treasury Stock IAC | Noncontrolling Interests | Noncontrolling Interests Angi Inc.
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Balance at beginning of period at Dec. 31, 2021 |  |  |  | $ 18,741 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase (Decrease) in Redeemable Noncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) earnings |  |  |  | (2,387) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other comprehensive loss |  |  |  | 0 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Distribution to and purchase of noncontrolling interests |  |  |  | (1,179) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Adjustment of noncontrolling interests to fair value |  |  |  | 24,041 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Vivian Health preferred shares, net of fees, and the reclassification and creation of noncontrolling interest |  |  |  |  | $ (11,782) |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other |  |  |  | (26) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at end of period at Jun. 30, 2022 |  |  |  | 27,408 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at beginning of period at Dec. 31, 2021 | $ 7,748,960 |  |  |  |  | $ 7,175,226 |  |  | $ 8 | $ 1 | $ 6,265,669 |  | $ 905,151 | $ 4,397 |  | $ 0 |  | $ 573,734 |
Balance at beginning of period (in shares) at Dec. 31, 2021 |  |  |  |  |  |  |  |  | 83,922 | 5,789 |  |  |  |  |  |  |  |  |
Increase (Decrease) in Stockholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) earnings | (1,113,905) |  |  |  |  | (1,104,928) |  |  |  |  |  |  | (1,104,928) |  |  |  |  | (8,977) |
Other comprehensive income, net of income taxes | (18,093) |  |  |  |  | (17,250) |  |  |  |  |  |  |  | (17,250) |  |  |  | (843) |
Stock-based compensation expense | 62,608 |  |  |  |  | 34,941 |  |  |  |  | 34,941 |  |  |  |  |  |  | 27,667 |
Issuance of common stock pursuant to stock-based awards, net of withholding taxes | (14,810) | $ (3,923) |  |  |  | (14,810) | $ (4,101) |  |  |  | (14,810) | $ (4,102) |  |  | $ 1 |  |  |  | $ 178
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares) |  |  |  |  |  |  |  |  | 210 |  |  |  |  |  |  |  |  |  |
Purchase of treasury stock |  | (8,144) | $ (59,079) |  |  |  | (8,144) | $ (59,079) |  |  |  | (8,144) |  |  |  |  | $ (59,079) |  |
Adjustment of noncontrolling interests to fair value | (24,041) |  |  |  |  | (24,041) |  |  |  |  | (24,041) |  |  |  |  |  |  |  |
Adjustment to the liquidation value of Vivian Health preferred shares | 54,700 |  |  |  |  | 11,526 |  |  |  |  | 11,526 |  |  |  |  |  |  | 43,174 |
Other | 890 |  |  |  |  | 890 |  |  |  |  | 890 |  |  |  |  |  |  |  |
Balance at end of period at Jun. 30, 2022 | 6,625,163 |  |  |  |  | 5,990,230 |  |  | $ 8 | $ 1 | 6,261,929 |  | (199,777) | (12,852) |  | (59,079) |  | 634,933 |
Balance at end of period (in shares) at Jun. 30, 2022 |  |  |  |  |  |  |  |  | 84,132 | 5,789 |  |  |  |  |  |  |  |  |
Balance at beginning of period at Mar. 31, 2022 |  |  |  | 27,817 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase (Decrease) in Redeemable Noncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) earnings |  |  |  | (2,353) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Distribution to and purchase of noncontrolling interests |  |  |  | (1,179) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Adjustment of noncontrolling interests to fair value |  |  |  | 14,905 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Issuance of Vivian Health preferred shares, net of fees, and the reclassification and creation of noncontrolling interest |  |  |  |  | $ (11,782) |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at end of period at Jun. 30, 2022 |  |  |  | 27,408 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at beginning of period at Mar. 31, 2022 | 7,500,917 |  |  |  |  | 6,919,455 |  |  | $ 8 | $ 1 | 6,249,328 |  | 669,353 | 765 |  | 0 |  | 581,462 |
Balance at beginning of period (in shares) at Mar. 31, 2022 |  |  |  |  |  |  |  |  | 84,075 | 5,789 |  |  |  |  |  |  |  |  |
Increase (Decrease) in Stockholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) earnings | (873,046) |  |  |  |  | (869,130) |  |  |  |  |  |  | (869,130) |  |  |  |  | (3,916) |
Other comprehensive income, net of income taxes | (14,392) |  |  |  |  | (13,616) |  |  |  |  |  |  |  | (13,616) |  |  |  | (776) |
Stock-based compensation expense | 32,350 |  |  |  |  | 18,239 |  |  |  |  | 18,239 |  |  |  |  |  |  | 14,111 |
Issuance of common stock pursuant to stock-based awards, net of withholding taxes | (798) | (1,450) |  |  |  | (798) | (2,328) |  |  |  | (798) | (2,327) |  |  | (1) |  |  |  | 878
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares) |  |  |  |  |  |  |  |  | 57 |  |  |  |  |  |  |  |  |  |
Purchase of treasury stock |  |  | (59,079) |  |  |  |  | (59,079) |  |  |  |  |  |  |  |  | (59,079) |  |
Adjustment of noncontrolling interests to fair value | (14,905) |  |  |  |  | (14,905) |  |  |  |  | (14,905) |  |  |  |  |  |  |  |
Adjustment to the liquidation value of Vivian Health preferred shares | 54,700 |  |  |  |  | 11,526 |  |  |  |  | 11,526 |  |  |  |  |  |  | 43,174 |
Other | 866 |  |  |  |  | 866 |  |  |  |  | 866 |  |  |  |  |  |  |  |
Balance at end of period at Jun. 30, 2022 | 6,625,163 |  |  |  |  | 5,990,230 |  |  | $ 8 | $ 1 | 6,261,929 |  | (199,777) | (12,852) |  | (59,079) |  | 634,933 |
Balance at end of period (in shares) at Jun. 30, 2022 |  |  |  |  |  |  |  |  | 84,132 | 5,789 |  |  |  |  |  |  |  |  |
Balance at beginning of period at Dec. 31, 2022 | 27,235 |  |  | 27,235 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase (Decrease) in Redeemable Noncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) earnings |  |  |  | (542) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Adjustment of noncontrolling interests to fair value |  |  |  | 8,089 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other |  |  |  | (4) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at end of period at Jun. 30, 2023 | 34,778 |  |  | 34,778 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at beginning of period at Dec. 31, 2022 | 6,572,534 |  |  |  |  | 5,931,614 |  |  | $ 8 | $ 1 | 6,295,080 |  | (265,019) | (13,133) |  | (85,323) |  | 640,920 |
Balance at beginning of period (in shares) at Dec. 31, 2022 |  |  |  |  |  |  |  |  | 84,184 | 5,789 |  |  |  |  |  |  |  |  |
Increase (Decrease) in Stockholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) earnings | 324,231 |  |  |  |  | 328,730 |  |  |  |  |  |  | 328,730 |  |  |  |  | (4,499) |
Other comprehensive income, net of income taxes | 6,720 |  |  |  |  | 6,227 |  |  |  |  |  |  |  | 6,227 |  |  |  | 493 |
Stock-based compensation expense | 61,265 |  |  |  |  | 36,127 |  |  |  |  | 36,127 |  |  |  |  |  |  | 25,138 |
Issuance of common stock pursuant to stock-based awards, net of withholding taxes | (4,575) | (4,113) |  |  |  | (4,575) | (6,572) |  |  |  | (4,575) | (6,574) |  |  | $ 2 |  |  |  | 2,459
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares) |  |  |  |  |  |  |  |  | 176 |  |  |  |  |  |  |  |  |  |
Purchase of treasury stock |  | (3,397) | (167,179) |  |  |  | (3,397) | (167,179) |  |  |  | (3,397) |  |  |  |  | (167,179) |  |
Adjustment of noncontrolling interests to fair value | (8,089) |  |  |  |  | (8,089) |  |  |  |  | (8,089) |  |  |  |  |  |  |  |
Adjustment to the liquidation value of Vivian Health preferred shares | 0 |  |  |  |  | 3,689 |  |  |  |  | 3,689 |  |  |  |  |  |  | (3,689) |
Other | 105 |  |  |  |  | 133 |  |  |  |  | 133 |  |  |  |  |  |  | (28) |
Balance at end of period at Jun. 30, 2023 | 6,777,502 |  |  |  |  | 6,116,708 |  |  | $ 8 | $ 1 | 6,312,394 |  | 63,711 | (6,904) |  | (252,502) |  | 660,794 |
Balance at end of period (in shares) at Jun. 30, 2023 |  |  |  |  |  |  |  |  | 84,360 | 5,789 |  |  |  |  |  |  |  |  |
Balance at beginning of period at Mar. 31, 2023 |  |  |  | 27,189 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Increase (Decrease) in Redeemable Noncontrolling Interests |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) earnings |  |  |  | (288) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Adjustment of noncontrolling interests to fair value |  |  |  | 7,881 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other |  |  |  | (4) |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at end of period at Jun. 30, 2023 | 34,778 |  |  | $ 34,778 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Balance at beginning of period at Mar. 31, 2023 | 6,920,480 |  |  |  |  | 6,267,301 |  |  | $ 8 | $ 1 | 6,306,229 |  | 152,756 | (14,641) |  | (177,052) |  | 653,179 |
Balance at beginning of period (in shares) at Mar. 31, 2023 |  |  |  |  |  |  |  |  | 84,257 | 5,789 |  |  |  |  |  |  |  |  |
Increase (Decrease) in Stockholders' Equity [Roll Forward] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net (loss) earnings | (91,342) |  |  |  |  | (89,045) |  |  |  |  |  |  | (89,045) |  |  |  |  | (2,297) |
Other comprehensive income, net of income taxes | 8,114 |  |  |  |  | 7,737 |  |  |  |  |  |  |  | 7,737 |  |  |  | 377 |
Stock-based compensation expense | 31,332 |  |  |  |  | 20,064 |  |  |  |  | 20,064 |  |  |  |  |  |  | 11,268 |
Issuance of common stock pursuant to stock-based awards, net of withholding taxes | (2,725) | (1,703) |  |  |  | (2,725) | (1,875) |  |  |  | (2,725) | (1,875) |  |  |  |  |  |  | $ 172
Issuance of common stock pursuant to stock-based awards, net of withholding taxes (in shares) |  |  |  |  |  |  |  |  | 103 |  |  |  |  |  |  |  |  |  |
Purchase of treasury stock |  | $ (3,397) | $ (75,450) |  |  |  | $ (3,397) | $ (75,450) |  |  |  | $ (3,397) |  |  |  |  | $ (75,450) |  |
Adjustment of noncontrolling interests to fair value | (7,881) |  |  |  |  | (7,881) |  |  |  |  | (7,881) |  |  |  |  |  |  |  |
Adjustment to the liquidation value of Vivian Health preferred shares | 0 |  |  |  |  | 1,877 |  |  |  |  | 1,877 |  |  |  |  |  |  | (1,877) |
Other | 74 |  |  |  |  | 102 |  |  |  |  | 102 |  |  |  |  |  |  | (28) |
Balance at end of period at Jun. 30, 2023 | $ 6,777,502 |  |  |  |  | $ 6,116,708 |  |  | $ 8 | $ 1 | $ 6,312,394 |  | $ 63,711 | $ (6,904) |  | $ (252,502) |  | $ 660,794 |
Balance at end of period (in shares) at Jun. 30, 2023 |  |  |  |  |  |  |  |  | 84,360 | 5,789 |  |  |  |  |  |  |  |  |

X
- Definition Adjustment of Redeemable Noncontrolling Interest to Fair Value + References No definition available. + Details
Name: | iaci_AdjustmentofRedeemableNoncontrollingInteresttoFairValue
Namespace Prefix: | iaci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Adjustments To Additional Paid In Capital, Adjustment To Liquidation Value + References No definition available. + Details
Name: | iaci_AdjustmentsToAdditionalPaidInCapitalAdjustmentToLiquidationValue
Namespace Prefix: | iaci_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Issuance of Common Stock, Shares, Pursuant to Stock-Based Awards, Net of Withholding Taxes + References No definition available. + Details
Name: | iaci_IssuanceOfCommonStockSharesPursuantToStockBasedAwardsNetOfWithholdingTaxes
Namespace Prefix: | iaci_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Issuance of Common Stock Pursuant to Stock-Based Awards, Net of Withholding Taxes + References No definition available. + Details
Name: | iaci_IssuanceofCommonStockPursuanttoStockBasedAwardsNetofWithholdingTaxes
Namespace Prefix: | iaci_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Other Comprehensive Income (Loss), Net of Tax, Attributable to Redeemable Noncontrolling Interest + References No definition available. + Details
Name: | iaci_OtherComprehensiveIncomeLossNetofTaxAttributabletoRedeemableNoncontrollingInterest
Namespace Prefix: | iaci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Other Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Nonredeemable Noncontrolling Interest, Total + References No definition available. + Details
Name: | iaci_OtherComprehensiveIncomeLossNetofTaxIncludingPortionAttributabletoNonredeemableNoncontrollingInterestTotal
Namespace Prefix: | iaci_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Temporary Equity, Creation of Noncontrolling Interest + References No definition available. + Details
Name: | iaci_TemporaryEquityCreationOfNoncontrollingInterest
Namespace Prefix: | iaci_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Temporary Equity, Distribution to and Purchase of Interest + References No definition available. + Details
Name: | iaci_TemporaryEquityDistributionToAndPurchaseOfInterest
Namespace Prefix: | iaci_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 35 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480483/718-10-35-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 20 -Section 55 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481089/718-20-55-13 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 718 -SubTopic 20 -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481089/718-20-55-12 + Details
Name: | us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. + References No definition available. + Details
Name: | us-gaap_IncreaseDecreaseInStockholdersEquityRollForward
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. + References No definition available. + Details
Name: | us-gaap_IncreaseDecreaseInTemporaryEquityRollForward
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Amount of Net Income (Loss) attributable to redeemable noncontrolling interest. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.19) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483621/220-10-S99-2 + Details
Name: | us-gaap_NetIncomeLossAttributableToRedeemableNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount after income tax of income (loss) including the portion attributable to nonredeemable noncontrolling interest. Excludes the portion attributable to redeemable noncontrolling interest recognized as temporary equity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section S99 -Paragraph 3A -Subparagraph (3) -SubTopic 10 -Topic 480 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 810 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1A -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481203/810-10-50-1A + Details
Name: | us-gaap_NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition As of the reporting date, the aggregate carrying amount of all noncontrolling interests which are redeemable by the (parent) entity (1) at a fixed or determinable price on a fixed or determinable date, (2) at the option of the holder of the noncontrolling interest, or (3) upon occurrence of an event that is not solely within the control of the (parent) entity. This item includes noncontrolling interest holder's ownership (or holders' ownership) regardless of the type of equity interest (common, preferred, other) including all potential organizational (legal) forms of the investee entity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Subparagraph (12)(c) -Section S99 -Paragraph 3A -Publisher FASB -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Subparagraph 14 -Paragraph 3A -Section S99 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Subparagraph 15 -Paragraph 3A -Section S99 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 480 -SubTopic 10 -Subparagraph (16)(c) -Paragraph 3A -Section S99 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480244/480-10-S99-3A + Details
Name: | us-gaap_RedeemableNoncontrollingInterestEquityCarryingAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 + Details
Name: | us-gaap_SharesIssued
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount of equity (deficit) attributable to parent and noncontrolling interest. Excludes temporary equity. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 24 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483421/250-10-45-24 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 23 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483421/250-10-45-23 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 45 -Paragraph 5 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483421/250-10-45-5 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 5 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479654/326-10-65-5 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 20 -Name Accounting Standards Codification -Section 65 -Paragraph 6 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 20 -Name Accounting Standards Codification -Section 65 -Paragraph 6 -Subparagraph (h)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 20 -Name Accounting Standards Codification -Section 65 -Paragraph 6 -Subparagraph (h)(1)(i) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 20 -Name Accounting Standards Codification -Section 65 -Paragraph 6 -Subparagraph (h)(1)(iii) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 20 -Name Accounting Standards Codification -Section 65 -Paragraph 6 -Subparagraph (h)(1)(iv) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 20 -Name Accounting Standards Codification -Section 65 -Paragraph 6 -Subparagraph (i)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480528/815-20-65-6 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 848 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (a)(3)(iii)(03) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483550/848-10-65-2 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 105 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 105 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 6 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479343/105-10-65-6 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (f)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 2 -Subparagraph (f)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480016/944-40-65-2 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 8 -Subparagraph (d)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 8 -Subparagraph (d)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482615/740-10-65-8 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 326 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 4 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479654/326-10-65-4 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 15 -Subparagraph (e) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 15 -Subparagraph (f)(1) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 65 -Paragraph 15 -Subparagraph (f)(2) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480336/718-10-65-15 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-1 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 815 -SubTopic 40 -Name Accounting Standards Codification -Section 65 -Paragraph 1 -Subparagraph (e)(3) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480175/815-40-65-1 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 250 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 7 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483443/250-10-50-7 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 220 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482765/220-10-50-5 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-1 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 17 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-17 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 45 -Paragraph 20 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481694/830-30-45-20 Reference 29: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 11 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480167/946-830-55-11 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 205 -Name Accounting Standards Codification -Section 45 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147480767/946-205-45-3 Reference 31: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 505 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481004/946-505-50-3 Reference 32: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(19)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 33: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.6-05(4)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-2 Reference 34: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(4)(b)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 35: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(6)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 36: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 220 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-09(7)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147483575/946-220-S99-3 Reference 37: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 38: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(g)(1)(ii)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480678/235-10-S99-1 Reference 39: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 323 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481687/323-10-50-3 Reference 40: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 825 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 28 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org//1943274/2147482907/825-10-50-28 Reference 41: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 15 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-15 Reference 42: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 45 -Paragraph 16 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481231/810-10-45-16 Reference 43: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 810 -SubTopic 10 -Section 55 -Paragraph 4I -Publisher FASB -URI https://asc.fasb.org//1943274/2147481175/810-10-55-4I + Details
Name: | us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition This element represents movements included in the statement of changes in stockholders' equity which are not separately disclosed or provided for elsewhere in the taxonomy. + References No definition available. + Details
Name: | us-gaap_StockholdersEquityOther
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Value of accretion of temporary equity to its redemption value during the period. + References No definition available. + Details
Name: | us-gaap_TemporaryEquityAccretionToRedemptionValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of increase (decrease) in temporary equity from changes classified as other. + References No definition available. + Details
Name: | us-gaap_TemporaryEquityOtherChanges
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Equity impact of the cost of common and preferred stock that were repurchased during the period. Recorded using the cost method. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 45 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481549/505-30-45-1 + Details
Name: | us-gaap_TreasuryStockValueAcquiredCostMethod
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration